Trump Picks Scott Gottlieb for FDA Commissioner

Mar 13, 2017

Bloomberg

Scott Gottlieb is President Donald Trump’s choice to lead the agency, according to Bloomberg sources at the White House.

Gottlieb, a former deputy commissioner of the FDA under George W. Bush, will look to cut th red tape at the FDA, enabling the agency to approve drugs, particularly generic drugs, more quickly.

Before accepting the position, Gottlieb would have to to resign from the pharmaceutical boards, and get rid of stock in companies he’d regulate at FDA. Gottlieb also must be confirmed by the Senate before he takes over at the agency.

Read the Bloomberg coverage

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments